Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Animal Health Market Size & Growth Forecast 2026–2035, By Segments (Product, Animal Type, Distribution Channel, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11039| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Animal Health Market size was valued at USD 67.6 Billion in 2025 and is anticipated to grow at a 10.4% CAGR from 2026 to 2035, crossing USD 181.82 Billion by 2035. The industry revenue for 2026 is estimated at USD 73.86 billion.

Base Year Value (2025)
USD 67.6 Billion
CAGR (2026-2035)
10.4%
Forecast Year Value (2035)
USD 181.82 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Animal Health Market Intelligence Snapshot

Regional Market Dynamics

  • North America holds 37.83% share due to mature veterinary care systems, high pet spending, and widespread preventive treatments supported by strong pharmaceutical and vaccine distribution networks.
  • Asia Pacific growth is driven by rising livestock production, expanding veterinary access, increasing disease management focus, and adoption of preventive care practices across farming and urban segments, at 11.65% CAGR.

Segment Momentum

  • Biologics accounted for 46.03% of the market in 2025 because vaccines and related products are widely used for disease prevention across livestock and companion animals, supporting routine veterinary care.
  • Companion animals are the fastest-growing segment as pet owners increasingly invest in preventive care, diagnostics, and long-term treatment, driving broader use of animal health products and services.

Market Expansion Drivers

  • Increasing AI integration in veterinary diagnostics and herd management accelerating technology-enabled animal care.
  • Rising pet humanization and animal healthcare expenditure strengthening companion animal treatment demand.
  • Expanding precision livestock monitoring platforms improving disease surveillance and farm productivity management.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Prominent players in the animal health market include Zoetis Inc. (United States), Merck & Co., Inc. (United States), Elanco Animal Health Incorporated (United States), Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale S.A. (France), Virbac S.A. (France), IDEXX Laboratories, Inc. (United States), Dechra Pharmaceuticals PLC (United Kingdom), Vetoquinol S.A. (France), Mars Incorporated (United States).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Increasing AI integration in veterinary diagnostics and herd management accelerating technology-enabled animal care

AI-enabled tools are changing how care decisions are made in the animal health market by improving the speed and consistency of diagnosis, treatment planning, and herd-level monitoring. In veterinary settings, image analysis, predictive triage, and clinical decision-support systems help practitioners detect conditions earlier and manage growing caseloads more efficiently, which is driving demand for diagnostic software, connected devices, and follow-on therapeutics. On the production side, AI-based herd management platforms turn continuous data from sensors, feeding systems, and health records into actionable alerts, allowing farmers and veterinarians to intervene before disease spreads or performance declines, reinforcing market demand for integrated animal health solutions rather than isolated products.

Rising pet humanization and animal healthcare expenditure strengthening companion animal treatment demand

As owners increasingly view pets as family members, spending behavior in the animal health market shifts from reactive treatment toward continuous, higher-value care. This changes purchasing patterns in favor of routine screening, chronic disease management, preventive vaccines, dermatology, dental care, and advanced therapeutics, supporting market expansion in companion animal products and services. Veterinary clinics and animal health companies respond by broadening treatment portfolios and investing in premium care pathways because pet owners are more willing to authorize diagnostics and longer treatment regimens, increasing market penetration for branded medicines and specialty care offerings.

Expanding precision livestock monitoring platforms improving disease surveillance and farm productivity management

Precision livestock monitoring is reshaping decision-making in the animal health market by linking animal behavior, intake, movement, and physiological indicators to earlier disease detection and tighter performance control. Producers adopt these platforms to reduce losses from delayed intervention, while veterinarians use the resulting data streams to guide targeted treatment and biosecurity actions, contributing to market size growth for sensor-based monitoring, diagnostics, and preventive health products. The practical effect is a more data-driven care model in which health spending is tied to measurable productivity outcomes, driving market development for solutions that combine surveillance capability with operational farm management value.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Increasing AI integration in veterinary diagnostics and herd management accelerating technology-enabled animal care 2.00% Moderate North America, Europe High Near Term
Rising pet humanization and animal healthcare expenditure strengthening companion animal treatment demand 1.80% Moderate North America, Asia Pacific High Mid Term
Expanding precision livestock monitoring platforms improving disease surveillance and farm productivity management 1.50% Moderate Europe, Asia Pacific Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
37.83% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held a 37.83% share of the animal health market in 2025, supported by its mature veterinary care ecosystem, high pet ownership spending, and broad use of preventive treatments across both companion and livestock animals. The region’s leadership is strengthened by well-established distribution channels for pharmaceuticals, vaccines, and diagnostic products, along with consistent adoption of routine checkups, parasite control, and herd health management programs. This operating environment keeps product demand steady and commercially scalable across clinics, hospitals, and farm networks.

Asia Pacific is projected to expand at an 11.65% CAGR over the forecast period, with growth in the animal health market being propelled by rising livestock production, increasing attention to animal disease management, and expanding access to veterinary services. Demand is accelerating as commercial farming operations adopt more structured health monitoring and vaccination practices, while urbanization and rising companion animal care are improving uptake of treatment and preventive care in city-based veterinary settings. The region’s momentum is also supported by the practical need to improve productivity and reduce disease-related losses across developing animal care systems.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Precision Veterinary Standards

Germany prioritizes evidence-based veterinary products and disease prevention across livestock and companion animal segments. Manufacturers focus on high-quality pharmaceuticals, vaccine development, and diagnostic technologies that support efficient animal health management.

France 🇫🇷

Livestock Health Optimization

France focuses on strengthening animal health through preventive livestock management, vaccination programs, and sustainable veterinary practices. Companies support farmers with advanced healthcare solutions that improve herd health while meeting evolving agricultural standards.

Italy 🇮🇹

Integrated Veterinary Solutions

Italy develops the animal health market through balanced investment in companion animal care and livestock disease prevention. Manufacturers emphasize veterinary pharmaceuticals, nutritional products, and diagnostics that support comprehensive animal healthcare practices.

Japan 🇯🇵

Preventive Animal Wellness

Japan advances the animal health market through preventive healthcare, pet wellness products, and specialized veterinary services. Companies invest in innovative diagnostics and targeted therapies that address the evolving needs of companion animal owners.

South Korea 🇰🇷

Modern Veterinary Expansion

South Korea strengthens the animal health market by expanding companion animal healthcare and improving livestock disease management. Industry participants introduce innovative pharmaceuticals and digital veterinary solutions that enhance clinical efficiency and preventive care.

United States 🇺🇸

Companion Care Innovation

The U.S. animal health market emphasizes advanced veterinary therapeutics, preventive care, and digital health solutions for companion and production animals. Companies expand diagnostic capabilities and integrated care platforms to improve treatment outcomes and livestock productivity.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Animal Health Market Share (%), Product, 2025

Biologics
Medicinal Feed Additives
Diagnostics
Equipment & Disposables
Others

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Product Segment Analysis: Biologics (Largest Segment) vs Diagnostics (Fastest-Growing Segment)

Biologics accounted for a 46.03% share of the animal health market in 2025, making it the leading product segment. This leadership is underpinned by the routine and large-scale use of vaccines and other biologic solutions in livestock and companion animal care, where prevention remains more practical and cost-effective than treating disease after outbreak. The biologics segment also benefits from established use across herd health programs and regular veterinary protocols, which helps preserve its share within the animal health market.

Diagnostics is emerging as the fastest-growing product segment in the animal health market as disease management increasingly depends on earlier and more precise detection. Growth is being reinforced through the practical need to confirm infections quickly, improve treatment decisions, and reduce unnecessary medication use across both veterinary clinics and production settings. Compared with traditional treatment-led approaches, diagnostics is gaining momentum because it fits the industry’s stronger focus on targeted care, surveillance, and operational efficiency.

Animal Type Segment Analysis: Production Animals (Largest Segment) vs Companion Animals (Fastest-Growing Segment)

Production Animals held the largest share of the animal health market in 2025. Their leading position reflects the consistent healthcare needs of livestock populations, where disease prevention, productivity protection, and herd-level management directly influence farm output and economic returns. Demand across this segment remains structurally strong because animal health spending for production animals is closely tied to maintaining meat, milk, and other livestock-related supply chains, supporting its continued share in the animal health market.

Companion Animals represent the fastest-growing animal type segment in the animal health market, influenced by rising attention to routine veterinary care and closer health monitoring for pets. This segment is expanding faster than production animals because care decisions are increasingly shaped by owner willingness to spend on preventive services, diagnostics, and long-term treatment support. As veterinary care for pets becomes more comprehensive, companion animals are gaining momentum through a broader and more frequent use of animal health products and services.

Segment Sub-Segment Largest Segment Fastest Growing
Product Biologics, Medicinal Feed Additives, Diagnostics, Equipment & Disposables, Others Biologics Diagnostics
Animal Type Production Animals, Companion Animals Production Animals Companion Animals
Distribution Channel Retail, E-Commerce, Hospital/ Clinic Pharmacy Hospital/ Clinic Pharmacy E-commerce
End-use Veterinary Reference Laboratories, Point-of-care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others Veterinary Hospitals & Clinics Point-of-care Testing/In-house Testing
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the animal health market:

1. Zoetis Inc. (United States)

2. Merck & Co. Inc. (United States)

3. Elanco Animal Health Incorporated (United States)

4. Boehringer Ingelheim International GmbH (Germany)

5. Ceva Santé Animale S.A. (France)

6. Virbac S.A. (France)

7. IDEXX Laboratories Inc. (United States)

8. Dechra Pharmaceuticals PLC (United Kingdom)

9. Vetoquinol S.A. (France)

10. Mars Incorporated (United States)

The animal health market continues to witness strategic expansion through acquisitions, portfolio diversification, and increased investment in advanced veterinary solutions. Industry participants are introducing innovative therapeutics, vaccines, and preventive care products aimed at improving livestock productivity and companion animal wellness. Growing attention toward disease prevention and precision animal care is also encouraging stronger R&D activity, while consolidation strategies are helping organizations broaden distribution capabilities and improve operational scale in emerging regions.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Covetrus Feb-26 Covetrus and MWI Animal Health have entered a definitive merger agreement valued at approximately USD 3.5 billion. The transaction integrates Covetrus’ technology-driven veterinary solutions with MWI’s extensive supply chain and distribution infrastructure, aiming to enhance product availability and operational scale across companion and production animal health segments.
Elanco May-26 Elanco has finalized the acquisition of AHV International, a move designed to bolster its dairy animal health portfolio. By incorporating AHV’s solutions, Elanco aims to strengthen its value-added offerings focused on transition cow health, animal well-being, and farm productivity, supporting its strategic expansion within international dairy markets.
Ceva Animal Health May-26 Ceva Animal Health and Mitsui & Co. have formed a strategic joint venture, Ceva Bussan Animal Health, in Japan. This partnership leverages localized operations to improve commercial access and distribution of animal health products, reinforcing Ceva’s regional market presence and deepening its collaborative relationship with Mitsui.
Zenex Animal Health Feb-26 Zenex Animal Health has acquired a majority stake in Netherlands-based VievePharm, a specialist in natural animal nutrition. The acquisition provides Zenex with a dedicated manufacturing and sales hub in Western Europe and leverages VievePharm’s existing distribution network to accelerate the commercialization of its therapeutic and nutritional products across the European Union.
MSD Animal Health Nov-24 MSD Animal Health has completed the acquisition of Elanco’s aquatic animal health business portfolio. The strategic transaction expands MSD’s global footprint in aquaculture health solutions, strengthening its specialized product offerings for fish and other aquatic species and reinforcing its competitive positioning in high-growth animal health segments.
Phibro Animal Health Nov-24 Phibro Animal Health has acquired Zoetis’ medicated feed additive portfolio, encompassing multiple product lines across various international markets. This acquisition enhances Phibro’s strategic position in feed-based animal health interventions and significantly increases its global commercial reach within the livestock health sector.
Kemin Industries Aug-25 Kemin Industries has acquired Hennessy Research Associates to bolster its internal vaccine development capabilities. This acquisition integrates advanced research and innovation assets into Kemin’s portfolio, supporting the company's expansion into next-generation vaccine technologies and reinforcing its position in animal nutrition and health solutions for livestock production.
Balmoral Funds Aug-25 Balmoral Funds has acquired Wilbur-Ellis Nutrition to establish a dedicated platform for custom animal feed solutions. The transaction increases the firm’s investment exposure to the animal nutrition sector and focuses on developing specialized feed products aimed at improving livestock productivity and operational efficiency across agricultural supply chains.
Yuyu Pharma Dec-25 Yuyu Pharma has made a strategic investment in Dalan Animal Health, a U.S.-based biotechnology firm focused on vaccines for honeybees and shrimp. This investment seeks to provide Yuyu Pharma with exposure to innovative vaccine technologies, supporting the development of resilient health solutions for the aquaculture and pollinator segments of the food system.
Patterson Companies Oct-24 Patterson Companies has acquired multiple veterinary businesses across the United Kingdom and the United States. This expansion strengthens the company's footprint in the animal health distribution market, enhancing its ability to provide veterinary products and services through a broader, more integrated international distribution network.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Animal Health Market — Custom Segments

Segment Sub-Segment
No segment data available.

Animal Health Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the animal health market?

The market valuation of the animal health is USD 73.86 billion in 2026.

What is the expected industry size of animal health by 2035?

Animal Health Market size is estimated to increase from USD 67.6 billion in 2025 to USD 181.82 billion by 2035 supported by a CAGR exceeding 10.4% during 2026-2035.

How is AI integration transforming technology adoption in the animal health market?

AI-enabled diagnostics and herd management platforms are shifting demand toward connected solutions that improve decision-making, enable earlier intervention, and combine health monitoring with operational efficiency.

How is pet humanization changing purchasing patterns in companion animal healthcare?

Increasing willingness to invest in preventive care, diagnostics, and advanced treatments is expanding demand for premium veterinary solutions and encouraging broader treatment portfolios from providers.

Why are biologics the largest product segment in the animal health market?

Biologics accounted for 46.03% of the market in 2025 because vaccines and related products are widely used for disease prevention across livestock and companion animals, supporting routine veterinary care.

Why are companion animals the fastest-growing animal type segment in the animal health market?

Companion animals are the fastest-growing segment as pet owners increasingly invest in preventive care, diagnostics, and long-term treatment, driving broader use of animal health products and services.

Why does North America hold the largest share in the animal health market?

North America holds 37.83% share due to mature veterinary care systems, high pet spending, and widespread preventive treatments supported by strong pharmaceutical and vaccine distribution networks.

What is driving growth in Asia Pacific animal health market?

Asia Pacific growth is driven by rising livestock production, expanding veterinary access, increasing disease management focus, and adoption of preventive care practices across farming and urban segments, at 11.65% CAGR.

Who are the major participants shaping the animal health landscape?

Prominent players in the animal health market include Zoetis Inc. (United States), Merck & Co., Inc. (United States), Elanco Animal Health Incorporated (United States), Boehringer Ingelheim International GmbH (Germany), Ceva Santé Animale S.A. (France), Virbac S.A. (France), IDEXX Laboratories, Inc. (United States), Dechra Pharmaceuticals PLC (United Kingdom), Vetoquinol S.A. (France), Mars Incorporated (United States).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →